Cargando…

QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis

Sunitinib is widely used as a first-line treatment for advanced renal cell carcinoma (RCC). However, a number of patients with RCC who receive sunitinib develop drug resistance; and the biological mechanisms involved in resistance to sunitinib remain unclear. It has previously been suggested that th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Tangliang, Zhou, Yulin, Wang, Qingyun, Yi, Xiaoming, Ge, Silun, He, Haowei, Xue, Song, Du, Bowen, Ge, Jingping, Dong, Jie, Qu, Le, Wang, Linhui, Zhou, Wenquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208629/ https://www.ncbi.nlm.nih.gov/pubmed/34036385 http://dx.doi.org/10.3892/ijo.2021.5228

Ejemplares similares

DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2019)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma
por: Du, Bowen, et al.
Publicado: (2020)

Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study
por: Tang, Chaopeng, et al.
Publicado: (2021)

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs
por: He, Haowei, et al.
Publicado: (2015)

AB247. MicroRNA expression profiling in clear cell renal cell carcinoma: identification and functional validation of key miRNAs
por: He, Haowei, et al.
Publicado: (2016)

Identification and Epigenetic Analysis of a Maternally Imprinted Gene Qpct
por: Guo, Jing, et al.
Publicado: (2015)

siRNA screen identifies QPCT as a druggable target for Huntington’s disease
por: Jimenez-Sanchez, Maria, et al.
Publicado: (2015)

Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy
por: Zhou, Yulin, et al.
Publicado: (2023)

Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

Apicidin confers promising therapeutic effect on acute myeloid leukemia cells via increasing QPCT expression
por: Liu, Lulu, et al.
Publicado: (2023)

Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis
por: Schloesser, Daniela, et al.
Publicado: (2022)

AB135. Leukemoid reaction associated with transitional cell carcinoma: a case report and literature review
por: He, Haowei, et al.
Publicado: (2016)

Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells
por: Wang, Yicun, et al.
Publicado: (2021)

Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort study
por: Qu, Le, et al.
Publicado: (2023)

Predicting CTCF-mediated chromatin loops using CTCF-MP
por: Zhang, Ruochi, et al.
Publicado: (2018)

Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis
por: Jiang, Huijiao, et al.
Publicado: (2023)

Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy
por: del Puerto-Nevado, L, et al.
Publicado: (2014)

Sunitinib Suppress Neuroblastoma Growth through Degradation of MYCN and Inhibition of Angiogenesis
por: Calero, Raul, et al.
Publicado: (2014)

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
por: Walraven, Maudy, et al.
Publicado: (2018)

p63 cooperates with CTCF to modulate chromatin architecture in skin keratinocytes
por: Qu, Jieqiong, et al.
Publicado: (2019)

Pyk2 promotes tumor progression in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2018)

Collecting Duct Carcinoma of the Kidney: A Single-Center Retrospective Study of 23 Cases
por: Tang, Chaopeng, et al.
Publicado: (2023)

AB043. Robot-assisted laparoscopic radical prostatectomy after previous transurethral resection of prostate: report of 14 cases
por: Zhou, Wenquan, et al.
Publicado: (2017)

Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3
por: Shen, Tianyi, et al.
Publicado: (2022)

AB071. The role of long non-coding RNAs in sunitinib resistance of renal cancer
por: Qu, Le, et al.
Publicado: (2017)

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma
por: Bianconi, Maristella, et al.
Publicado: (2016)

Costunolide Induces Autophagy and Apoptosis by Activating ROS/MAPK Signaling Pathways in Renal Cell Carcinoma
por: Fu, Dian, et al.
Publicado: (2020)

An Artificial CTCF Peptide Triggers Efficient Therapeutic Efficacy in Ocular Melanoma
por: Wen, Xuyang, et al.
Publicado: (2020)

Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer
por: Wang, Anbang, et al.
Publicado: (2019)

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
por: Kontovinis, Loukas F, et al.
Publicado: (2009)

CTCF and cellular heterogeneity
por: Ren, Gang, et al.
Publicado: (2019)

Loss of Maternal CTCF Is Associated with Peri-Implantation Lethality of Ctcf Null Embryos
por: Moore, James M., et al.
Publicado: (2012)

CTCF: an R/bioconductor data package of human and mouse CTCF binding sites
por: Dozmorov, Mikhail G, et al.
Publicado: (2022)

An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis
por: Li, Jiao, et al.
Publicado: (2019)

EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome
por: Sato, Mototaka, et al.
Publicado: (2013)

Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma
por: Peng, Qiang, et al.
Publicado: (2019)

Angiopoietin-like protein 3 blocks nuclear import of FAK and contributes to sorafenib response
por: Bao, Yi, et al.
Publicado: (2018)

Deletion of CTCF sites in the SHH locus alters enhancer–promoter interactions and leads to acheiropodia
por: Ushiki, Aki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_amqm5om1ht69pq8j8s963utrla